Stock listing
ATHEX:VIDAVO Vidavo SA Μετοχή
Follow Vidavo SA into a list and get an email when it puts out news.
Share price · ATHEX:VIDAVO
€8.55 EUR 0.00 (0.0%)
Close on Nov 19, 2026
- Day range
- €8.55 – €8.55 EURNov 19, 2026
- Market cap
- €8.91M EURAt the close on Nov 19, 2026 · price × 1.04M shares outstanding
- 52-week range
- €5.60 – €11.50 EURLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- €4,714 EURMedian day 100 shares · 26 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ATHEX:VIDAVO · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €8.55 | 0.00 | 0.0% | €8.55 | €8.55 | €8.55 | 0 | |
| €8.55 | 0.00 | 0.0% | €8.90 | €8.90 | €8.55 | 1 | |
| €8.55 | 0.00 | 0.0% | €8.55 | €8.55 | €8.55 | 0 | |
| €8.55 | -0.40 | -4.5% | €8.40 | €8.60 | €8.40 | 600 | |
| €8.95 | 0.00 | 0.0% | €8.95 | €8.95 | €8.95 | 0 | |
| €8.95 | +0.15 | +1.7% | €8.80 | €8.95 | €8.55 | 700 | |
| €8.80 | -0.20 | -2.2% | €8.70 | €8.95 | €8.65 | 935 | |
| €9.00 | -0.35 | -3.7% | €8.90 | €9.00 | €8.45 | 6,925 | |
| €9.35 | -0.15 | -1.6% | €9.10 | €9.60 | €9.10 | 220 | |
| €9.50 | +0.20 | +2.2% | €9.50 | €9.50 | €9.50 | 100 | |
| €9.30 | 0.00 | 0.0% | €9.30 | €9.30 | €9.30 | 0 | |
| €9.30 | -0.25 | -2.6% | €9.30 | €9.45 | €9.20 | 600 | |
| €9.55 | -0.25 | -2.6% | €9.25 | €9.70 | €9.15 | 1,311 | |
| €9.80 | +0.30 | +3.2% | €9.80 | €9.80 | €9.80 | 100 | |
| €9.50 | -0.05 | -0.5% | €9.20 | €9.55 | €9.10 | 323 | |
| €9.55 | 0.00 | 0.0% | €9.40 | €9.55 | €9.40 | 11 | |
| €9.55 | -0.35 | -3.5% | €10.00 | €10.00 | €9.55 | 1,550 | |
| €9.90 | -0.05 | -0.5% | €9.55 | €9.90 | €9.55 | 750 | |
| €9.95 | 0.00 | 0.0% | €9.60 | €9.95 | €9.50 | 900 | |
| €9.95 | -0.05 | -0.5% | €9.70 | €10.00 | €9.70 | 450 | |
| €10.00 | 0.00 | 0.0% | €9.70 | €10.00 | €9.70 | 550 | |
| €10.00 | 0.00 | 0.0% | €10.00 | €10.00 | €10.00 | 0 | |
| €10.00 | -0.10 | -1.0% | €9.60 | €10.00 | €9.50 | 2,578 | |
| €10.10 | 0.00 | 0.0% | €10.10 | €10.10 | €10.10 | 0 | |
| €10.10 | 0.00 | 0.0% | €10.10 | €10.10 | €10.10 | 0 | |
| €10.10 | 0.00 | 0.0% | €10.10 | €10.10 | €10.10 | 0 | |
| €10.10 | 0.00 | 0.0% | €10.10 | €10.10 | €10.10 | 0 | |
| €10.10 | +0.10 | +1.0% | €10.00 | €10.10 | €10.00 | 250 | |
| €10.00 | -0.10 | -1.0% | €10.00 | €10.10 | €9.70 | 250 | |
| €10.10 | -0.20 | -1.9% | €9.70 | €10.20 | €9.65 | 451 | |
| €10.30 | 0.00 | 0.0% | €10.30 | €10.30 | €10.30 | 250 | |
| €10.30 | 0.00 | 0.0% | €10.30 | €10.30 | €10.30 | 0 | |
| €10.30 | -0.10 | -1.0% | €9.90 | €10.30 | €9.90 | 340 | |
| €10.40 | -0.10 | -1.0% | €10.30 | €10.50 | €10.30 | 250 | |
| €10.50 | 0.00 | 0.0% | €10.50 | €10.50 | €10.50 | 0 | |
| €10.50 | +0.10 | +1.0% | €10.50 | €10.50 | €9.75 | 134 | |
| €10.40 | -0.20 | -1.9% | €10.40 | €10.60 | €10.40 | 35 | |
| €10.60 | 0.00 | 0.0% | €10.60 | €10.60 | €10.60 | 0 | |
| €10.60 | 0.00 | 0.0% | €10.60 | €10.60 | €10.60 | 0 | |
| €10.60 | 0.00 | 0.0% | €10.60 | €10.60 | €10.50 | 321 | |
| €10.60 | -0.10 | -0.9% | €10.90 | €10.90 | €10.50 | 124 | |
| €10.70 | 0.00 | 0.0% | €10.70 | €10.70 | €10.70 | 0 | |
| €10.70 | -0.10 | -0.9% | €11.50 | €11.50 | €10.60 | 950 | |
| €10.80 | 0.00 | 0.0% | €10.00 | €11.00 | €10.00 | 35 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | 0.00 | 0.0% | €10.80 | €10.80 | €10.80 | 0 | |
| €10.80 | +0.20 | +1.9% | €10.10 | €10.80 | €10.00 | 1,835 | |
| €10.60 | 0.00 | 0.0% | €10.60 | €10.60 | €10.60 | 0 | |
| €10.60 | +0.20 | +1.9% | €10.00 | €10.60 | €9.65 | 4,634 | |
| €10.40 | 0.00 | 0.0% | €10.40 | €10.40 | €10.40 | 1 | |
| €10.40 | 0.00 | 0.0% | €10.40 | €10.40 | €10.40 | 0 | |
| €10.40 | +0.50 | +5.1% | €10.40 | €10.40 | €10.40 | 0 | |
| €9.90 | -0.50 | -4.8% | €9.90 | €10.40 | €9.90 | 1 | |
| €10.40 | -0.10 | -1.0% | €10.60 | €10.60 | €9.85 | 942 | |
| €10.50 | 0.00 | 0.0% | €10.50 | €10.50 | €10.50 | 0 | |
| €10.50 | 0.00 | 0.0% | €10.50 | €10.50 | €10.50 | 0 | |
| €10.50 | +0.10 | +1.0% | €10.50 | €10.50 | €10.50 | 102 | |
| €10.40 | 0.00 | 0.0% | €10.40 | €10.40 | €10.40 | 0 | |
| €10.40 | -0.10 | -1.0% | €10.40 | €10.40 | €10.40 | 350 | |
| €10.50 | +0.10 | +1.0% | €10.40 | €10.50 | €10.40 | 800 | |
| €10.40 | +0.10 | +1.0% | €10.40 | €10.40 | €10.40 | 250 | |
| €10.30 | +0.10 | +1.0% | €9.20 | €10.30 | €9.20 | 700 |
- Ticker
- ATHEX:VIDAVO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- ATHEX
- Currency
- EUR
Vidavo SA on 6ix
- Sector
- Health care
- Industry
- Health care services
- Decks
- 1 deck · latest April 2015
Valuation
P/E 15.0× against a median of 74.0×: 3rd lowest of 5 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- €7.51M EUR
- P/E
- 15.0×
- EV/sales
- 3.5×
- EV/EBITDA
- 9.2×
- Price/book
- 4.1×
- Gross margin
- 55.2%
- Operating margin
- 35.4%
- Net margin
- 27.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Vidavo SA · ATHEX:VIDAVO | US$9.78M | US$8.25M | 15.0× | 3.5× | 9.2× | 4.1× | 27.4% | 0.0× | n/a |
| Republic Healthcare Limited · HKEX:8357 | US$10.83M | US$9.29M | n/a | 1.2× | n/a | 1.8× | −40.3% | 0.4× | n/a |
| Scandinavian Medical Solutions A/S · OMXCOP:SMSMED | US$10.61M | US$21.25M | 2,780× | 0.6× | 13.9× | 1.0× | 0.0% | 1.0× | n/a |
| Medilines Distributors, Inc. · PSE:MEDIC | US$10.33M | US$9.37M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | n/a |
| KT Medical Service Public Company Limited · SET:KTMS | US$10.25M | US$8.24M | 9.6× | 0.4× | 2.8× | 0.6× | 5.1% | 0.0× | n/a |
| Morefield Group N.V. · EURONEXT:MORE | US$10.12M | US$75.51M | 2.2× | 0.4× | 2.6× | 0.4× | 2.6% | 3.1× | n/a |
| Concord Medical Services Holdings Ltd. · NYSE:CCM | US$9.99M | US$509.8M | n/a | 7.4× | n/a | n/a | −20.2% | n/a | 0.49 |
| AIML Innovations Inc · CSE:AIML | US$9.68M | US$11.23M | n/a | 369× | n/a | n/a | n/a | n/a | 0.33 |
| UCrest Bhd · MYX:UCREST | US$9.05M | US$6.78M | 138× | 2.0× | 34.7× | 0.9× | 1.9% | 0.0× | n/a |
| HeartSciences Inc. · NASDAQ:HSCS | US$8.99M | US$8.96M | n/a | 1,984× | n/a | n/a | n/a | n/a | 1.23 |
| PainChek Ltd · ASX:PCK | US$8.86M | US$7.71M | n/a | 3.1× | n/a | n/a | −238.8% | n/a | n/a |
| Median of the others | US$10.06M | US$9.33M | 74.0× | 2.0× | 8.4× | 0.8× | 0.0% | 0.2× | 0.49 |
Team and board
| Officer | Role |
|---|---|
| Pantelis Angelidis | Founder |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2015) | Investor deck | 8 slides | April 2015 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.16M | 1.10M | 697.2K | 638.4K | 374.9K | 311.9K | 280.4K |
| Cost of revenue | 967.8K | 729.1K | 186.7K | 226.2K | 59.2K | 34.8K | 47.1K |
| Gross profit | 1.19M | 366.5K | 510.5K | 412.2K | 315.7K | 277.1K | 233.3K |
| Research and development | 297.2K | 251.9K | 677.1K | 928.7K | 737.0K | 434.4K | 336.9K |
| Selling, general and administrative | 55.1K | 103.6K | 133.3K | 126.0K | 84.9K | 54.8K | 61.6K |
| Operating income | 765.4K | -18.9K | 154.4K | -35.4K | 113.4K | 111.3K | 96.5K |
| Depreciation and amortization | 55.3K | 30.3K | 34.4K | 22.6K | 18.5K | 13.5K | 13.1K |
| EBITDA | 820.8K | 11.4K | 188.8K | -12.8K | 132.0K | 124.7K | 109.6K |
| Interest expense | 7.61K | 4.79K | 11.7K | 3.17K | 3.58K | 3.31K | 3.40K |
| Income before tax | 757.8K | -27.6K | 142.7K | -93.2K | 102.8K | 98.2K | 104.3K |
| Net income | 593.1K | -30.4K | 123.9K | -100.8K | 59.8K | 92.6K | 101.9K |
| Earnings per share, basic | 0.57 | -0.03 | 0.13 | -0.12 | 0.07 | 0.11 | 0.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 738.4K | 182.8K | 206.7K | 81.3K | 99.7K | 329.5K | 97.1K |
| Receivables | 1.10M | 95.9K | 86.2K | 109.1K | 114.1K | 123.9K | 136.0K |
| Inventory | 63.9K | 42.1K | 35.5K | 30.8K | 52.9K | 40.7K | 34.2K |
| Current assets | 2.21M | 645.6K | 1.11M | 1.22M | 1.56M | 1.28M | 1.39M |
| Total assets | 2.85M | 1.19M | 1.46M | 1.53M | 1.87M | 1.55M | 1.72M |
| Accounts payable | 535.4K | 97.4K | 116.4K | 137.0K | 902 | 285 | 1.97K |
| Current liabilities | 851.6K | 286.3K | 509.1K | 676.4K | 918.6K | 745.9K | 962.8K |
| Total liabilities | 1.04M | 448.2K | 693.0K | 887.4K | 1.13M | 864.3K | 1.13M |
| Shareholders' equity | 1.81M | 736.9K | 763.4K | 639.6K | 742.7K | 683.3K | 591.8K |
| Shares outstanding | 1.05M | 933.9K | 932.9K | 856.3K | 856.5K | 856.9K | 857.1K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 180.9K | 212.2K | 238.7K | -15.0K | -206.2K | 234.3K | -108.5K |
| Capital spending | -207.4K | -240.0K | -94.1K | -7.91K | -23.2K | -1.01K | -77.4K |
| Free cash flow | -26.4K | -27.8K | 144.5K | -22.9K | -229.4K | 233.3K | -185.9K |
| Share buybacks | -165 | -2.25K | -396 | -1.10K | 0 | ||
| Change in cash | 555.7K | -23.9K | 125.4K | -18.4K | -229.8K | 232.3K | -185.4K |
Cap table
Built by 6ix from Vidavo SA’s releases
- Common shares
- 1,041,998
- Fully diluted
- 1,041,998
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,041,998 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,041,998 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Pantelis Angelidis | Founder · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Vidavo SA.